The move jettisons the name of a storied Massachusetts biotechnology company that helped transform the drug industry in the 1980s and anchored the life sciences cluster.

The buildings at 1 Mountain Road and 5 Mountain Road, located in Framingham Technology Park, were acquired by the partnership in 2019. Biotech company Sanofi Genzyme was the seller and will continue ...

Drugmaker Genzyme has sold two Framingham office buildings for about $20.5 million. The company has had operations in Framingham for decades and has said it's committed to keeping a presence in ...

Genzyme recently cut 95 jobs in Framingham, while TJX and Staples, both headquartered in the city, have slashed a combined 477 workers in undisclosed locations.

Sanofi, the French pharmaceutical giant that acquired Genzyme seven years ago, said Wednesday that it will be laying off 95 workers at its Framingham manufacturing site.

Sanofi Genzyme, the French company’s rare-disease division based in Cambridge, Massachusetts, announced it is laying off 130 people at a manufacturing facility in Boston.

FRAMINGHAM — Sanofi Genzyme is doubling down on its investment in the Framingham Technology Park. The drug maker plans to increase the size of its ongoing expansion project in Framingham with a ...

Genzyme's Framingham, MA, plant came to the rescue last year, supplying its rare-disease drug Fabrazyme that had been in short supply after viral contamination forced the closure of another ...

Framingham is where Genzyme last year opened a $330 million manufacturing plant, in part using a $14.3 million grant from the state-created Massachusetts Life Sciences Center – the quasi-public ...